Don’t Sell Viscofan, S.A. (BME:VIS) Before You Read This

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it practical, we’ll show how Viscofan, S.A.’s (BME:VIS) P/E ratio could help you assess the value on offer. Viscofan has a price to earnings ratio of 20.98, based on the last twelve months. That means that at current prices, buyers pay €20.98 for every €1 in trailing yearly profits.

See our latest analysis for Viscofan

How Do You Calculate A P/E Ratio?

The formula for price to earnings is:

Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Or for Viscofan:

P/E of 20.98 = €55.75 ÷ €2.66 (Based on the trailing twelve months to December 2018.)

Is A High P/E Ratio Good?

A higher P/E ratio means that buyers have to pay a higher price for each €1 the company has earned over the last year. That isn’t necessarily good or bad, but a high P/E implies relatively high expectations of what a company can achieve in the future.

How Growth Rates Impact P/E Ratios

Earnings growth rates have a big influence on P/E ratios. Earnings growth means that in the future the ‘E’ will be higher. That means unless the share price increases, the P/E will reduce in a few years. A lower P/E should indicate the stock is cheap relative to others — and that may attract buyers.

Viscofan’s earnings per share were pretty steady over the last year. But EPS is up 5.4% over the last 5 years.

How Does Viscofan’s P/E Ratio Compare To Its Peers?

The P/E ratio essentially measures market expectations of a company. You can see in the image below that the average P/E (17.1) for companies in the food industry is lower than Viscofan’s P/E.

BME:VIS Price Estimation Relative to Market, April 1st 2019
BME:VIS Price Estimation Relative to Market, April 1st 2019

That means that the market expects Viscofan will outperform other companies in its industry. The market is optimistic about the future, but that doesn’t guarantee future growth. So investors should always consider the P/E ratio alongside other factors, such as whether company directors have been buying shares.

Don’t Forget: The P/E Does Not Account For Debt or Bank Deposits

The ‘Price’ in P/E reflects the market capitalization of the company. Thus, the metric does not reflect cash or debt held by the company. In theory, a company can lower its future P/E ratio by using cash or debt to invest in growth.

Such spending might be good or bad, overall, but the key point here is that you need to look at debt to understand the P/E ratio in context.

How Does Viscofan’s Debt Impact Its P/E Ratio?

Net debt totals just 3.7% of Viscofan’s market cap. It would probably trade on a higher P/E ratio if it had a lot of cash, but I doubt it is having a big impact.

The Verdict On Viscofan’s P/E Ratio

Viscofan’s P/E is 21 which is above average (17.7) in the ES market. Given the debt is only modest, and earnings are already moving in the right direction, it’s not surprising that the market expects continued improvement.

Investors have an opportunity when market expectations about a stock are wrong. As value investor Benjamin Graham famously said, ‘In the short run, the market is a voting machine but in the long run, it is a weighing machine.’ So this free report on the analyst consensus forecasts could help you make a master move on this stock.

But note: Viscofan may not be the best stock to buy. So take a peek at this free list of interesting companies with strong recent earnings growth (and a P/E ratio below 20).

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.